Artefact as the pathologist's friend: Peritumoral retraction in in situ and infiltrating duct carcinoma of the breast

International Journal of Surgical Pathology

Volumn 15, Issue 1, 2007, Pages 53-59

  Irie, Junji ^a   Manucha, Varsha ^a   Ioffe, Olga B ^a,b   Silverberg, Steven G ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

Breast carcinoma; Differential diagnosis; Ductal carcinoma in situ; Infiltrating duct carcinoma; Peritumoral retraction artefact; Prelymphatic system; Prostatic carcinoma

Indexed keywords

EOSIN; HEMATOXYLIN;

ARTICLE; ARTIFACT; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER RESEARCH; CANCER STAGING; CARCINOMA IN SITU; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DUCTAL CARCINOMA IN SITU; HUMAN; HUMAN TISSUE; INFILTRATING DUCT CARCINOMA; LABORATORY DIAGNOSIS; LYMPHATIC SYSTEM; NEEDLE BIOPSY; PRIORITY JOURNAL; STAINING; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TISSUE SECTION; TUMOR CELL;

ARTIFACTS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; TISSUE FIXATION; TUMOR MARKERS, BIOLOGICAL;

EID: 33845360016     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/1066896906295690     Document Type: Article

References (44)

1. The American Heritage Dictionary of the English Language: Fourth Edition. Boston, Mass: Houghton Mifflin Company ; 2000.
2. Yeh I. Atlas of Microscopic Artifacts and Foreign Materials. Baltimore, Md: Williams & Wilkins ; 1997.
3. Elston CW, Ellis IO. The Breast. Edinburgh, United Kingdom: Churchill Livingstone ; 1998.
4. Fechner RE, Mills SE. Breast Pathology. Benign Proliferations, Atypias and in Situ Carcinomas. Chicago, Ill: American Society of Clinical Pathologists ; 1990.
5. Page DL, Anderson TJ, eds. Diagnostic Histopathology of the Breast. Edinburgh, United Kingdom: Churchill Livingstone ; 1987.
6. Rosen PP, Oberman HA. Atlas of Tumor Pathology. Tumors of the Mammary Gland. Washington, DC: Armed Forces Institute of Pathology ; 1992.
7. Rosen PP. Rosen's Breast Pathology. Philadelphia, Pa: Lipincott Williams & Wilkins ; 2001.
8. Silverberg SG. Atlas of Breast Pathology. Philadelphia, Pa: W.B. Saunders Company ; 2002.
9. Tavassoli F. Pathology of the Breast. New York: Elsevier Science Publishing Co ; 1999.
10. Ioffe OB, Silverberg SG. Infiltrating Carcinoma: Infiltrating duct carcinoma not otherwise specified and prognostic factors other than histologic type. In: Silverberg SG, ed. Atlas of Breast Pathology. Philadelphia, Pa: W. B. Saunders ; 2002: 117-137.
11. Schnitt SJ, Connolly JL, Harris JR, Hellman S, Cohen RB. Pathologic predictors of early local recurrence in stage I and stage II breast cancer treated by primary radiation therapy. Cancer. 1984 ; 53: 1049-1057.
12. Fisher ER, Gregorio RM, Fisher B, Redmond C, Velliios F, Sommers SC. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Cancer Project (protocol no. 4). Cancer. 1975 ; 36: 1-85.
13. Gage I, Schnitt SJ, Nixon AJ, et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer. 1996 ; 78: 1921-1928.
14. Voogd AC, Peterse JL, Crommelin MA, et al. Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study on local recurrence after breast conservation. Eur J Cancer. 1999 ; 35: 1828-1837.
15. Connolly JL, Boyages J, Nixon AJ, et al. Predictors of breast recurrence after conservative surgery and radiation therapy for invasive breast cancer. Mod Pathol. 1998 ; 11: 134-139.
16. Bose S, Derosa CM, Ozello L. Immunostaining of type IV collagen and smooth muscle actin as an aid in the diagnosis of breast lesions. Breast J. 1999 ; 5: 194-201.
17. Moritani S, Kushima R, Sugihara H, et al. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections. Mod Pathol. 2002 ; 15: 397-405.
18. Nayar R, Breland C, Bedrossian U, et al. immunoreactivity of ductal cells with putative myoepithelial markers: a potential pitfall in breast carcinoma. Ann Diagn Pathol. 1999 ; 3: 165-173.
19. Prasad ML, Hyjek E, Giri DD, et al. Double immunolabeling with cytokeratin and smooth-muscle actin in confirming early invasive carcinoma of breast. Am J Surg Pathol. 1999 ; 23: 176-181.
20. Werling RW, Hwang H, Yaziji H, et al. Immunohistochemical distinction of invasive from noninvasive breast lesions. A comparative study of p63 versus calponin and smooth muscle myosin heavy chain. Am J Surg Pathol. 2003 ; 27: 82-90.
21. Yaziji H, Gown AM, Sneige N. Detection of stromal invasion in breast cancer: the myoepithelial markers. Adv Anat Pathol. 2000 ; 7: 100-109.
22. Pinder S, Ellis IO, O'Rourke S, et al. Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large series with a long-term follow-up. Histopathol. 1994 ; 24: 41-47.
23. Rosen PP. Tumor emboli in intramammary lymphatics in breast carcinoma: pathologic criteria for diagnosis and clinical significance. Pathol Annu. 1983 ; 18: 215-232.
24. Clemente CG, Boracchi P, Andreola S, et al. Peritumoral lymphatic invasion in patients with node-negative mammary duct carcinoma. Cancer. 1992 ; 69: 1396-1403.
25. Ioffe OB, Silverberg SG. Intraductal carcinoma and atypical ductal hyperplasia. In: Silverberg SG, ed. Atlas of Breast Pathology. Philadelphia, Pa: W.B. Saunders ; 2002.
26. Orbo A, Stalsberg H, Kunde D. Topographic criteria in the diagnosis of tumor emboli in intramammary lymphatics. Cancer. 1990 ; 66: 972-977.
27. Lee AKC, DeLellis RA, Wolfe HJ. Intramammary lymphatic invasion in breast carcinomas. Evaluation using ABH isoantigens as endothelial markers. Am J Surg Pathol. 1986 ; 10: 589-594.
28. Saigo PE, Rosen PP. The immunohistochemical stains to identify endothelial-lined channels in mammary carcinoma. Cancer. 1987 ; 59: 51-54.
29. Akishima Y, Ito K, Zhang L, et al. Immunohistochemical detection of human small lymphatic vessels under normal and pathological conditions using the LYVE-1 antibody. Virchows Arch. 2004 ; 444: 153-157.
30. Rodin AA, Larson DL, Roberts DK. Nature of the perineural space invaded by prostatic carcinoma. Cancer. 1967 ; 20: 1772-1779.
31. Stamp GW. Tenascin distribution in basal cell carcinomas. J Pathol. 1989 ; 159: 225-229.
32. Halpert B, Sheehan EE, Schmalhorst WR, Scott R Jr. Carcinoma of the prostate. A study of 5,000 autopsies. Cancer. 1963 ; 16: 737-742.
33. Durham JR, Lee MW, Amin MB, Shulz DS, Stetler-Stevenson WG. Clefting in adenocarcinoma of the prostate gland [abstract]. Am J Clin Pathol. 1994 ; 102: 536-536.
34. Varma M, Lee MW, Tamboli P, et al. Morphologic criteria for the diagnosis of prostatic adenocarcinoma in needle biopsy specimens: a study of 25 consecutive cases in a routine surgical pathology practice. Arch Pathol Lab Med. 2002 ; 126: 554-561.
35. Kruslin B, Tomas D, Rogatsch H, et al. Periacinar retraction clefting in the prostatic needle core biopsies: an important diagnostic criterion or a simple artifact. Virchows Arch. 2003 ; 443: 524-527.
36. Khayyata S, Basturk O, Adsay NV. Invasive micropapillary carcinomas of the ampullo-pancreatbiliary region and their association with tumor-infiltrating neutrophils. Mod Pathol. 2005 ; 18: 1504-1511.
37. Li Y, Kaneko M, Sakamoto DG, Takeshima Y, Inai K. The reversed apical pattern of MUC1 expression is characteristic of invasive micropapillary carcinoma of the breast. Breast Cancer. 2006 ; 13: 58-63.
38. Nagi C, Guttman M, Jaffer S, et al. N-cadherin expression in breast cancer: correlation with an aggressive histologic variant - invasive micropapillary carcinoma. Breast Cancer Res. 2005 ; 94: 225-235.
39. Damiani S, Eusebi V, Peterse JL. Malignant neoplasms infiltrating pseudoangiomatous' stromal hyperplasia of the breast: an unrecognized pathway of tumour spread. Histopathology. 2002 ; 41: 208-215.
40. Hartveit E. Attenuated cells in breast stroma: the missing lymphatic system of the breast. Histopathology. 1990 ; 16: 533-543.
41. Dumoff KL, Pasha T, Xu X, et al. Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis in human breast carcinoma [abstract]. Mod Pathol. 2006 ; 19: 26A - 26A. Abstract 108.
42. Rodin AA, Larson DL, Roberts DK. Nature of the perineural space invaded by prostatic carcinoma. Cancer. 1967 ; 20: 1772-1779.
43. Baisden BL, Kahane H, Epstein JI. Perineural invasion, mucinous fibroplasias, and glomerulations: diagnostic features of limited cancer on prostate needle biopsy. Am J Surg Pathol. 1999 ; 23: 918-924.
44. Bismar TA, Lewis JS, Vollmer R, et al. Multiple measures of carcinoma extent versus perineural invasion in prostate biopsy tissue in prediction of pathologic stage in a screening population. Am J Surg Pathol. 2003 ; 27: 432-440.